1 | 1-20190 | - | - | - | - | [1] 93 93 💬
|
2 | 11C-csar | - | - | - | - | [2] 93 93, 94 💬
|
3 | 13-15MG/KG/D ursodeoxycholic | - | - | - | - | [1] 93 93 💬
|
4 | 18-22MG/KG/D ursodeoxycholic | - | - | - | - | [1] 93 93 💬
|
5 | 2MG CS0159 | - | - | - | - | [1] 93 93 💬
|
6 | 3 MG [14C]-A4250 capsule | - | - | - | - | [3] 93 93, 297, 338 💬
|
7 | 3-({[(3R,5R)-3-butyl-3-ethyl-7-(methyloxy)-1,1-dioxido-5-phenyl-2,3,4,5-tetrahydro-1,4-benzothiazepin-8-YL]methyl}amino)pentanedioic acid | - | - | - | - | [1] 93 93 💬
|
8 | 3A,7A-dihydroxy-6A-ethyl-5ßcholan-24-OIC acid | - | - | - | - | [1] 93 93 💬
|
9 | 6 alpha-ethylchenodeoxycholic acid (6-edca), OCA, INT-747 | - | - | - | - | [1] 93 93 💬
|
10 | 6-ecdca | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
11 | 6?-ethylchenodeoxycholic acid (6-ecdca), OCA, INT-747 | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
12 | 6A-ethylchenodeoxycholic acid (6-ecdca), OCA, INT-747 | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
13 | 6A-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
14 | 6A-ethylchenodeoxycholic acid , 6-ethylchenodeoxycholic acid, 3A,7A-dihydroxy-6A-ethyl-5ßcholan-24-O | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
15 | 6A-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
16 | 6A-ethylchenodeoxycholic acid, 6-ethylchenodeoxycholic acid, 3A,7A-dihydroxy-6A-ethyl-5ßcholan-24-O | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
17 | A11ha02 | - | - | - | - | [1] 93 93 💬
|
18 | A4250 | - | - | - | - | [4] 93 93, 296, 297, 338 💬
|
19 | Abatacept | [1] Abatacept Abatacept | [1] Abatacept
Abatacept
💬
| [2] CD80 CD80, CD86 💬
| [13] Allograft rejection Allograft rejection, Autoimmune thyroid disease, Cell adhesion molecules, Graft-versus-host disease, Intestinal immune network for IgA production, Kaposi sarcoma-associated herpesvirus infection, Rheumatoid arthritis, Systemic lupus erythematosus, Toll-like receptor signaling pathway, Transcriptional misregulation in cancer, Type I diabetes mellitus, Viral myocarditis, Virion - Adenovirus 💬 | [26] 2 2, 13, 19, 41, 44, 46, 49, 50, 51, 53, 55, 60, 65, 84, 93, 95, 96, 97, 107, 160, 164, 222, 271, 284, 285, 300 💬
|
20 | Acido obeticolico | - | - | - | - | [3] 93 93, 94, 296 💬
|
21 | Acido ursodessicolico | - | - | - | - | [1] 93 93 💬
|
22 | Alkaline phosphatase | [1] Alkaline Phosphatase Alkaline Phosphatase | - | - | - | [3] 46 46, 93, 97 💬
|
23 | Alpha-ethylchenodeoxycholic acid (6-edca), OCA, INT-747 | - | - | - | - | [1] 93 93 💬
|
24 | APD334 | - | - | - | - | [5] 93 93, 96, 97, 98, 269 💬
|
25 | ASC42 10 MG | - | - | - | - | [1] 93 93 💬
|
26 | ASC42 15 MG | - | - | - | - | [1] 93 93 💬
|
27 | ASC42 5 MG | - | - | - | - | [1] 93 93 💬
|
28 | Atorvastatin | [1] Atorvastatin Atorvastatin | [2] Atorvastatin calcium
Atorvastatin calcium
,
Atorvastatin
💬
| [1] HMGCR HMGCR 💬
| [3] AMPK signaling pathway AMPK signaling pathway, Bile secretion, Terpenoid backbone biosynthesis 💬 | [17] 13 13, 22, 46, 49, 51, 58, 79, 84, 88, 93, 96, 97, 160, 225, 271, 297, 299 💬
|
29 | Babaodan capsule | - | - | - | - | [1] 93 93 💬
|
30 | Baricitinib | [1] Baricitinib Baricitinib | [1] Baricitinib
Baricitinib
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [19] 2 2, 13, 41, 46, 49, 50, 51, 53, 54, 93, 107, 135, 162, 265, 268, 269, 300, 325, 345 💬
|
31 | BCD-085 | - | - | - | - | [2] 93 93, 271 💬
|
32 | Bezafibrat genericon retard 400 MG | - | - | - | - | [1] 93 93 💬
|
33 | Bezafibrate | [1] Bezafibrate Bezafibrate | [1] Bezafibrate
Bezafibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [8] 20 20, 93, 94, 160, 296, 316, 324, 344 💬
|
34 | Bezafibrate 100 MG | [1] Bezafibrate Bezafibrate | [1] Bezafibrate
Bezafibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
35 | Bezafibrate 200 MG | [1] Bezafibrate Bezafibrate | [1] Bezafibrate
Bezafibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
36 | Bezafibrate 200 MG IN addition TO udca therapy | [2] Bezafibrate Bezafibrate, Ursodeoxycholic acid | [2] Ursodiol
Ursodiol
,
Bezafibrate
💬
| [2] NR1C1 NR1C1, NR1H4 💬
| [11] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
37 | Bezafibrate 200 MG oral tablet | [1] Bezafibrate Bezafibrate | [1] Bezafibrate
Bezafibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
38 | Bezafibrate 400 MG | [1] Bezafibrate Bezafibrate | [1] Bezafibrate
Bezafibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
39 | Bezafibrate 400 MG IN addition TO udca therapy | [2] Bezafibrate Bezafibrate, Ursodeoxycholic acid | [2] Ursodiol
Ursodiol
,
Bezafibrate
💬
| [2] NR1C1 NR1C1, NR1H4 💬
| [11] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
40 | Bezafibrate IR | [1] Bezafibrate Bezafibrate | [1] Bezafibrate
Bezafibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
41 | Bezafibrate SR | [1] Bezafibrate Bezafibrate | [1] Bezafibrate
Bezafibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
42 | Bezafibrate, beza, BZF, bezalip | [1] Bezafibrate Bezafibrate | [1] Bezafibrate
Bezafibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
43 | Bezafibrate, beza, BZF, bezalip mono | [1] Bezafibrate Bezafibrate | [1] Bezafibrate
Bezafibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
44 | Bezafilbrate IR | - | - | - | - | [1] 93 93 💬
|
45 | Bezalip | - | - | - | - | [2] 93 93, 94 💬
|
46 | Biological: mesenchymal stem cell | - | - | - | - | [1] 93 93 💬
|
47 | Budesonide | [1] Budesonide Budesonide | [1] Budesonide
Budesonide
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [7] 66 66, 93, 94, 95, 96, 97, 98 💬
|
48 | Calcium | [2] Calcium Calcium, Calcium carbonate | [2] Calcium carbonate
Calcium carbonate
,
Calcium carbonate
💬
| - | - | [12] 6 6, 46, 49, 68, 93, 95, 97, 156, 222, 235, 271, 274 💬
|
49 | Cilofexor | [1] Cilofexor Cilofexor | - | - | - | [2] 93 93, 94 💬
|
50 | CNP-104 | - | - | - | - | [1] 93 93 💬
|
51 | CNTO1275 | - | - | - | - | [6] 46 46, 49, 84, 93, 96, 97 💬
|
52 | Colchicine | [1] Colchicine Colchicine | [1] Colchicine
Colchicine
💬
| [9] TUBB TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB, TUBB 💬
| [11] Alzheimer disease Alzheimer disease, Amyotrophic lateral sclerosis, Gap junction, Huntington disease, Motor proteins, Parkinson disease, Pathogenic Escherichia coli infection, Pathways of neurodegeneration - multiple diseases, Phagosome, Prion disease, Salmonella infection 💬 | [8] 42 42, 46, 50, 56, 93, 97, 210, 266 💬
|
53 | Combination antiviral therapy | - | - | - | - | [1] 93 93 💬
|
54 | CR845 1.0 MG | - | - | - | - | [1] 93 93 💬
|
55 | CS0159 | - | - | - | - | [2] 93 93, 94 💬
|
56 | Cyclophosphamide | [1] Cyclophosphamide Cyclophosphamide | [2] Cyclophosphamide
Cyclophosphamide
,
Cyclophosphamide
💬
| - | - | [44] 11 11, 13, 14, 16, 19, 20, 26, 28, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 56, 60, 62, 65, 66, 84, 93, 96, 162, 164, 172, 205, 221, 222, 224, 265, 274, 283, 284, 285, 288, 326, 331 💬
|
57 | Cyclosporin A | [1] Cyclosporine Cyclosporine | [1] Cyclosporine
Cyclosporine
💬
| [5] PPP3C PPP3C, PPP3C, PPP3C, PPP3R, PPP3R 💬
| [33] Alzheimer disease Alzheimer disease, Amphetamine addiction, Amyotrophic lateral sclerosis, Axon guidance, B cell receptor signaling pathway, C-type lectin receptor signaling pathway, Calcium signaling pathway, Cellular senescence, Dopaminergic synapse, Glucagon signaling pathway, Glutamatergic synapse, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human immunodeficiency virus 1 infection, Kaposi sarcoma-associated herpesvirus infection, Lipid and atherosclerosis, Long-term potentiation, MAPK signaling pathway, Natural killer cell mediated cytotoxicity, Oocyte meiosis, Osteoclast differentiation, Oxytocin signaling pathway, PD-L1 expression and PD-1 checkpoint pathway in cancer, Pathways of neurodegeneration - multiple diseases, Prion disease, Renin secretion, T cell receptor signaling pathway, Th1 and Th2 cell differentiation, Th17 cell differentiation, Tuberculosis, VEGF signaling pathway, Wnt signaling pathway, cGMP-PKG signaling pathway 💬 | [11] 46 46, 49, 53, 54, 56, 60, 62, 93, 95, 113, 164 💬
|
58 | Denosumab | [1] Denosumab Denosumab | [1] Denosumab
Denosumab
💬
| [1] TNFSF11 TNFSF11 💬
| [8] Breast cancer Breast cancer, Chemical carcinogenesis - receptor activation, Cytokine-cytokine receptor interaction, NF-kappa B signaling pathway, Osteoclast differentiation, Parathyroid hormone synthesis, secretion and action, Prolactin signaling pathway, Rheumatoid arthritis 💬 | [10] 46 46, 50, 70, 75, 77, 93, 95, 96, 274, 299 💬
|
59 | E6011 | - | - | - | - | [4] 46 46, 93, 96, 97 💬
|
60 | EDP-305 | - | - | - | - | [1] 93 93 💬
|
61 | EDP-305 dose 1 | - | - | - | - | [1] 93 93 💬
|
62 | EDP-305 dose 2 | - | - | - | - | [1] 93 93 💬
|
63 | Elafibranor | [1] Elafibranor Elafibranor | [1] Elafibranor
Elafibranor
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [2] 93 93, 94 💬
|
64 | Elafibranor 120 MG | [1] Elafibranor Elafibranor | [1] Elafibranor
Elafibranor
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [2] 93 93, 94 💬
|
65 | Elafibranor 80 MG | [1] Elafibranor Elafibranor | [1] Elafibranor
Elafibranor
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [2] 93 93, 94 💬
|
66 | Elafibranor 80MG | [1] Elafibranor Elafibranor | [1] Elafibranor
Elafibranor
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
67 | Emtricitabine | [1] Emtricitabine Emtricitabine | [1] Emtricitabine
Emtricitabine
💬
| - | - | [3] 13 13, 93, 325 💬
|
68 | EP547 | - | - | - | - | [2] 93 93, 94 💬
|
69 | EP547 tablet 25MG | - | - | - | - | [2] 93 93, 94 💬
|
70 | EP547 tablet 75MG | - | - | - | - | [2] 93 93, 94 💬
|
71 | Ezetimibe | [1] Ezetimibe Ezetimibe | [1] Ezetimibe
Ezetimibe
💬
| [1] NPC1L1 NPC1L1 💬
| [1] Fat digestion and absorption Fat digestion and absorption 💬 | [4] 79 79, 93, 149, 260 💬
|
72 | Ezetrol | [1] Ezetimibe Ezetimibe | [1] Ezetimibe
Ezetimibe
💬
| [1] NPC1L1 NPC1L1 💬
| [1] Fat digestion and absorption Fat digestion and absorption 💬 | [2] 93 93, 260 💬
|
73 | EZT | - | - | - | - | [1] 93 93 💬
|
74 | Fecal microbiota | [1] Fecal microbiota Fecal microbiota | - | - | - | [5] 13 13, 49, 93, 96, 97 💬
|
75 | Fenofibrate | [1] Fenofibrate Fenofibrate | [1] Fenofibrate
Fenofibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [6] 8 8, 79, 93, 94, 97, 265 💬
|
76 | Fenofibrate 200MG | [1] Fenofibrate Fenofibrate | [1] Fenofibrate
Fenofibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
77 | Fenofibrate combined with ursodeoxycholic acid | [2] Fenofibrate Fenofibrate, Ursodeoxycholic acid | [2] Fenofibrate
Fenofibrate
,
Ursodiol
💬
| [2] NR1C1 NR1C1, NR1H4 💬
| [11] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Bile secretion, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
78 | Fenofibrate IN combination with ursodeoxycholic acid | [1] Fenofibrate Fenofibrate | [1] Fenofibrate
Fenofibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
79 | FFP104 | - | - | - | - | [2] 93 93, 96 💬
|
80 | Fully human monoclonal antibody directed against CXCL10 | - | - | - | - | [1] 93 93 💬
|
81 | Fuzhenghuayu | - | - | - | - | [1] 93 93 💬
|
82 | Genetic analysis | - | - | - | - | [7] 34 34, 85, 90, 93, 94, 96, 234 💬
|
83 | GFT505 | - | - | - | - | [2] 93 93, 94 💬
|
84 | GKT137831 | - | - | - | - | [2] 85 85, 93 💬
|
85 | Golexanolone | [1] Golexanolone Golexanolone | - | - | - | [1] 93 93 💬
|
86 | GR3027 | - | - | - | - | [1] 93 93 💬
|
87 | GS-9674 | - | - | - | - | [2] 93 93, 94 💬
|
88 | GS-9674 100 MG | - | - | - | - | [1] 93 93 💬
|
89 | GS-9674 30 MG | - | - | - | - | [1] 93 93 💬
|
90 | GSK2330672 | - | - | - | - | [1] 93 93 💬
|
91 | GSK2330672/linerixibat 40 MG | [1] Linerixibat Linerixibat | [1] Linerixibat
Linerixibat
💬
| [1] SLC10A2 SLC10A2 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
92 | GYPP-06 (GKT137831 free base), C10071301-D | - | - | - | - | [1] 93 93 💬
|
93 | Hesperidin | [1] Hesperidin Hesperidin | [1] Hesperidin
Hesperidin
💬
| - | - | [1] 93 93 💬
|
94 | High protein high fiber diet | - | - | - | - | [2] 93 93, 95 💬
|
95 | ICG | - | - | - | - | [3] 93 93, 94, 235 💬
|
96 | INT-747 | - | - | - | - | [1] 93 93 💬
|
97 | INT-747, OCA | - | - | - | - | [2] 93 93, 94 💬
|
98 | IPN60190 | - | - | - | - | [2] 93 93, 94 💬
|
99 | K-808 | - | - | - | - | [1] 93 93 💬
|
100 | Linerixibat | [1] Linerixibat Linerixibat | [1] Linerixibat
Linerixibat
💬
| [1] SLC10A2 SLC10A2 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
101 | Linerixibat (GSK2330672) 40 MG | [1] Linerixibat Linerixibat | [1] Linerixibat
Linerixibat
💬
| [1] SLC10A2 SLC10A2 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
102 | Linerixibat (GSK2330672) 45 MG | [1] Linerixibat Linerixibat | [1] Linerixibat
Linerixibat
💬
| [1] SLC10A2 SLC10A2 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
103 | Linerixibat (GSK2330672) 45MG | [1] Linerixibat Linerixibat | [1] Linerixibat
Linerixibat
💬
| [1] SLC10A2 SLC10A2 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
104 | LJN452 | - | - | - | - | [1] 93 93 💬
|
105 | LJN452, 0,01 MG | - | - | - | - | [1] 93 93 💬
|
106 | LJN452, 0,03 MG | - | - | - | - | [1] 93 93 💬
|
107 | LJN452, 0,1 MG | - | - | - | - | [1] 93 93 💬
|
108 | LUM001 | - | - | - | - | [5] 93 93, 94, 296, 297, 338 💬
|
109 | LY3009104 | - | - | - | - | [10] 46 46, 49, 50, 93, 107, 135, 265, 268, 325, 345 💬
|
110 | MBX 8025 | - | - | - | - | [1] 93 93 💬
|
111 | MBX-8025 | - | - | - | - | [3] 79 79, 93, 94 💬
|
112 | MBX-8025, dsic | - | - | - | - | [1] 93 93 💬
|
113 | MBX-8025, formulation 2 | - | - | - | - | [1] 93 93 💬
|
114 | Methotrexate | [1] Methotrexate Methotrexate | [2] Methotrexate
Methotrexate
,
Methotrexate sodium
💬
| [2] DHFR DHFR, DHFR 💬
| [3] Folate biosynthesis Folate biosynthesis, Folate transport and metabolism, One carbon pool by folate 💬 | [37] 11 11, 13, 19, 34, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 54, 55, 60, 62, 65, 84, 93, 96, 97, 107, 162, 164, 172, 256, 270, 271, 284, 285, 286, 326, 331 💬
|
115 | Methylprednisolone | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [45] 2 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 96, 97, 127, 162, 164, 222, 224, 271, 283, 284, 285, 296, 300 💬
|
116 | Methylprednisolone and azathioprine | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 93 93, 95 💬
|
117 | Methylprednisolone and mycophenolate mofetil | [1] Methylprednisolone Methylprednisolone | [2] Methylprednisolone
Methylprednisolone
,
Methylprednisolone acetate
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [2] 93 93, 95 💬
|
118 | Minodronic acid | [1] Minodronic acid Minodronic acid | - | - | - | [4] 6 6, 46, 93, 95 💬
|
119 | Modafinil | [1] Modafinil Modafinil | [1] Modafinil
Modafinil
💬
| - | - | [4] 6 6, 13, 49, 93 💬
|
120 | Moexipril | [1] Moexipril Moexipril | [2] Moexipril hydrochloride
Moexipril hydrochloride
,
Moexipril
💬
| [1] ACE ACE 💬
| [6] Chagas disease Chagas disease, Coronavirus disease - COVID-19, Diabetic cardiomyopathy, Hypertrophic cardiomyopathy, Renin secretion, Renin-angiotensin system 💬 | [1] 93 93 💬
|
121 | Mycophenolate mofetil | [2] Mycophenolate mofetil Mycophenolate mofetil, Mycophenolic acid | [4] Mycophenolate mofetil
Mycophenolate mofetil
,
Mycophenolate mofetil hydrochloride
,
Mycophenolate sodium
,
Mycophenolic acid
💬
| [2] IMPDH IMPDH, IMPDH 💬
| [2] Drug metabolism - other enzymes Drug metabolism - other enzymes, Purine metabolism 💬 | [32] 2 2, 11, 13, 19, 20, 28, 35, 36, 42, 43, 44, 46, 49, 51, 53, 60, 62, 63, 65, 66, 93, 95, 96, 164, 222, 224, 226, 234, 283, 284, 285, 300 💬
|
122 | Nalmefene | [1] Nalmefene Nalmefene | [3] Nalmefene hydrochloride
Nalmefene hydrochloride
,
Nalmefene
,
Nalmefene hydrochloride hydrate
💬
| [3] OPRD1 OPRD1, OPRK1, OPRM1 💬
| [7] Estrogen signaling pathway Estrogen signaling pathway, Hormone signaling, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Sphingolipid signaling pathway, cGMP-PKG signaling pathway 💬 | [2] 6 6, 93 💬
|
123 | NCA 500MG | - | - | - | - | [1] 93 93 💬
|
124 | NGM282 | - | - | - | - | [2] 93 93, 94 💬
|
125 | NI-0801 | - | - | - | - | [1] 93 93 💬
|
126 | Norucholic acid (NCA) 500 MG | [1] norUrsodeoxycholic acid norUrsodeoxycholic acid | - | - | - | [1] 93 93 💬
|
127 | Obeticholic acid | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [3] 93 93, 265, 296 💬
|
128 | Obeticholic acid 10 MG | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
129 | Obeticholic acid 5 MG | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
130 | Obeticholic acid tablets | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
131 | OCA | - | - | - | - | [3] 93 93, 94, 296 💬
|
132 | Ocaliva | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [2] 93 93, 296 💬
|
133 | Ocaliva 10MG | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
134 | Ocaliva 5MG | [1] Obeticholic acid Obeticholic acid | [1] Obeticholic acid
Obeticholic acid
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
135 | Olumiant | [1] Baricitinib Baricitinib | [1] Baricitinib
Baricitinib
💬
| [2] JAK1 JAK1, JAK2 💬
| [37] AGE-RAGE signaling pathway in diabetic complications AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬 | [9] 46 46, 49, 93, 107, 135, 265, 268, 325, 345 💬
|
136 | Part 1: LJN452 | - | - | - | - | [1] 93 93 💬
|
137 | Part 2: LJN452 dose level 1 | - | - | - | - | [1] 93 93 💬
|
138 | Part 2: LJN452 dose level 2 | - | - | - | - | [1] 93 93 💬
|
139 | Pemafibrate | [1] Pemafibrate Pemafibrate | [1] Pemafibrate
Pemafibrate
💬
| [1] NR1C1 NR1C1 💬
| [10] Adipocytokine signaling pathway Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Glucagon signaling pathway, Hepatitis C, Insulin resistance, Non-alcoholic fatty liver disease, PPAR signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
140 | Pentoxifylline | [1] Pentoxifylline Pentoxifylline | [1] Pentoxifylline
Pentoxifylline
💬
| - | - | [11] 26 26, 56, 84, 93, 96, 97, 113, 220, 222, 296, 298 💬
|
141 | Phenylbutyrate | [1] Phenylbutyric acid Phenylbutyric acid | [1] Sodium phenylbutyrate
Sodium phenylbutyrate
💬
| - | - | [7] 2 2, 93, 94, 244, 251, 297, 338 💬
|
142 | Prednisone | [1] Prednisone Prednisone | [1] Prednisone
Prednisone
💬
| [1] NR3C1 NR3C1 💬
| [1] Neuroactive ligand-receptor interaction Neuroactive ligand-receptor interaction 💬 | [54] 2 2, 11, 13, 14, 18, 19, 26, 28, 35, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 53, 60, 61, 63, 64, 65, 66, 79, 81, 84, 85, 86, 90, 93, 95, 96, 97, 113, 145, 162, 164, 205, 222, 224, 228, 251, 269, 283, 285, 288, 299, 300, 303, 307, 331 💬
|
143 | Probiotic | [1] Lactobacillus acidophilus Lactobacillus acidophilus | [1] Lactomin
Lactomin
💬
| - | - | [9] 2 2, 6, 93, 96, 97, 127, 193, 266, 299 💬
|
144 | PVT201 | - | - | - | - | [1] 93 93 💬
|
145 | Pyridoxine 10MG BP | [1] Pyridoxine Pyridoxine | [2] Pyridoxine hydrochloride
Pyridoxine hydrochloride
,
Pyridoxine
💬
| - | - | [1] 93 93 💬
|
146 | Questran | [1] Cholestyramine Cholestyramine | [1] Cholestyramine resin
Cholestyramine resin
💬
| - | - | [4] 93 93, 254, 297, 338 💬
|
147 | Raltegravir | [1] Raltegravir Raltegravir | [2] Raltegravir
Raltegravir
,
Raltegravir potassium
💬
| - | - | [4] 13 13, 26, 93, 265 💬
|
148 | Rhudex 100 MG (127 MG rhudex choline salt) granules | - | - | - | - | [1] 93 93 💬
|
149 | Rhudex 25 MG (31.75 MG rhudex choline salt) granules | - | - | - | - | [1] 93 93 💬
|
150 | Rhudex 50 MG (63.5 MG rhudex choline salt) granules | - | - | - | - | [1] 93 93 💬
|
151 | Rifampicin | [1] Rifampin Rifampin | [2] Rifampin
Rifampin
,
Rifampicin sodium
💬
| - | - | [8] 6 6, 13, 17, 46, 93, 97, 299, 338 💬
|
152 | Rifaximin | [1] Rifaximin Rifaximin | [1] Rifaximin
Rifaximin
💬
| - | - | [8] 6 6, 65, 93, 96, 97, 99, 296, 299 💬
|
153 | Risedronic acid | [1] Risedronic acid Risedronic acid | [3] Risedronate sodium
Risedronate sodium
,
Risedronic acid
,
Risedronate sodium monohydrate
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [3] 93 93, 95, 274 💬
|
154 | Rituximab | [1] Rituximab Rituximab | [1] Rituximab
Rituximab
💬
| [1] MS4A1 MS4A1 💬
| [1] Hematopoietic cell lineage Hematopoietic cell lineage 💬 | [52] 11 11, 13, 14, 19, 26, 34, 35, 36, 40, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 62, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 162, 172, 220, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331 💬
|
155 | S-adenosyl-L-methionine | - | - | - | - | [1] 93 93 💬
|
156 | S-adenosyl-methionine (same) capsules | - | - | - | - | [1] 93 93 💬
|
157 | Saroglitazar magnesium 1 MG | [1] Saroglitazar Saroglitazar | [2] Saroglitazar
Saroglitazar
,
Saroglitazar magnesium
💬
| [3] NR1C1 NR1C1, NR1C2, NR1C3 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
158 | Saroglitazar magnesium 2 MG | [1] Saroglitazar Saroglitazar | [2] Saroglitazar
Saroglitazar
,
Saroglitazar magnesium
💬
| [3] NR1C1 NR1C1, NR1C2, NR1C3 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
159 | Saroglitazar magnesium 4 MG | [1] Saroglitazar Saroglitazar | [2] Saroglitazar
Saroglitazar
,
Saroglitazar magnesium
💬
| [3] NR1C1 NR1C1, NR1C2, NR1C3 💬
| [22] AMPK signaling pathway AMPK signaling pathway, Acute myeloid leukemia, Adipocytokine signaling pathway, Alcoholic liver disease, Chemical carcinogenesis - receptor activation, Diabetic cardiomyopathy, Efferocytosis, Glucagon signaling pathway, Hepatitis C, Huntington disease, Insulin resistance, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer, Wnt signaling pathway, cAMP signaling pathway 💬 | [1] 93 93 💬
|
160 | Seladelpar | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [2] 93 93, 94 💬
|
161 | Seladelpar / MBX-8025 200 MG | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
162 | Seladelpar / MBX-8025 50 MG | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
163 | Seladelpar 10 MG | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
164 | Seladelpar 10 MG capsule | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
165 | Seladelpar 10 MG or less | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
166 | Seladelpar 5 MG | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
167 | Seladelpar 5 MG capsule | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
168 | Seladelpar 5-10 MG | [1] Seladelpar Seladelpar | [2] Seladelpar
Seladelpar
,
Seladelpar lysine
💬
| [1] NR1C3 NR1C3 💬
| [12] AMPK signaling pathway AMPK signaling pathway, Efferocytosis, Huntington disease, Lipid and atherosclerosis, Longevity regulating pathway, Non-alcoholic fatty liver disease, Osteoclast differentiation, PPAR signaling pathway, Pathways in cancer, Thermogenesis, Thyroid cancer, Transcriptional misregulation in cancer 💬 | [1] 93 93 💬
|
169 | Setanaxib | [1] Setanaxib Setanaxib | - | - | - | [2] 93 93, 218 💬
|
170 | Sortis 10 MG | - | - | - | - | [1] 93 93 💬
|
171 | Standard OF care: udca | - | - | - | - | [1] 93 93 💬
|
172 | Sublimated mare milk | - | - | - | - | [1] 93 93 💬
|
173 | T cell injection targeting CD19 chimeric antigen receptor | - | - | - | - | [6] 46 46, 49, 51, 53, 93, 300 💬
|
174 | Tauroursodeoxycholic acid capsules | [1] Tauroursodeoxycholic acid Tauroursodeoxycholic acid | [1] Taurursodiol
Taurursodiol
💬
| - | - | [1] 93 93 💬
|
175 | TDF/FTC/LPV/R | - | - | - | - | [1] 93 93 💬
|
176 | Tenofovir disoproxil | [2] Tenofovir Tenofovir, Tenofovir disoproxil | [4] Tenofovir disoproxil fumarate
Tenofovir disoproxil fumarate
,
Tenofovir
,
Tenofovir disoproxil phosphate
,
Tenofovir disoproxil maleate
💬
| - | - | [1] 93 93 💬
|
177 | Tetrathiomolybdate | [1] Tetrathiomolybdate Tetrathiomolybdate | - | - | - | [3] 85 85, 93, 171 💬
|
178 | Thiamine | [1] Thiamine Thiamine | [3] Thiamine hydrochloride
Thiamine hydrochloride
,
Thiamine mononitrate
,
Thiamine
💬
| - | - | [3] 13 13, 93, 265 💬
|
179 | Tiamin DAK | - | - | - | - | [2] 93 93, 97 💬
|
180 | Tiamin SAD | - | - | - | - | [2] 93 93, 97 💬
|
181 | Tigecycline | [1] Tigecycline Tigecycline | [1] Tigecycline
Tigecycline
💬
| - | - | [1] 93 93 💬
|
182 | TQA3526 | - | - | - | - | [1] 93 93 💬
|
183 | Tropifexor | [1] Tropifexor Tropifexor | [1] Tropifexor
Tropifexor
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
184 | Udca | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [5] 67 67, 93, 94, 97, 296 💬
|
185 | Umbilical cord derived mesenchymal stem cell (UC -MSC) transplantation | - | - | - | - | [2] 93 93, 296 💬
|
186 | Ursodeoxycholic acid | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [8] 6 6, 67, 84, 93, 94, 95, 96, 97 💬
|
187 | Ursodeoxycholic acid 300MG capsule | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
188 | Ursodeoxycholic acid 300MG tablet | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
189 | Ursodeoxycholic acid capsules | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
190 | Ursodeoxycholic acid combination OF immunosuppressive agents | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [2] 93 93, 95 💬
|
191 | Ursodeoxycholic acid combined with total glucosides OF paeony | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
192 | Ursodeoxycholic acid only | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
193 | UrsodeoxycholsäURE | - | - | - | - | [1] 93 93 💬
|
194 | Ursodiol | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [6] 8 8, 20, 93, 97, 234, 299 💬
|
195 | Ursofalk | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [4] 93 93, 94, 96, 97 💬
|
196 | Ursofalk® 500 MG FILM-coated tablets | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
197 | Ursofalk® 500 MG filmtabletten | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
198 | Ursofalk® capsules | [1] Ursodeoxycholic acid Ursodeoxycholic acid | [1] Ursodiol
Ursodiol
💬
| [1] NR1H4 NR1H4 💬
| [1] Bile secretion Bile secretion 💬 | [1] 93 93 💬
|
199 | Ustekinumab | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [16] 37 37, 40, 41, 46, 49, 50, 53, 56, 65, 84, 93, 96, 97, 162, 269, 271 💬
|
200 | Ustekinumab 180 MG | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 93 93 💬
|
201 | Ustekinumab 45 MG | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [1] 93 93 💬
|
202 | Ustekinumab 90 MG | [1] Ustekinumab Ustekinumab | [1] Ustekinumab
Ustekinumab
💬
| [3] IL12A IL12A, IL12B, IL23A 💬
| [28] African trypanosomiasis African trypanosomiasis, Alcoholic liver disease, Allograft rejection, Amoebiasis, C-type lectin receptor signaling pathway, Chagas disease, Coronavirus disease - COVID-19, Cytokine-cytokine receptor interaction, Herpes simplex virus 1 infection, Inflammatory bowel disease, Influenza A, JAK-STAT signaling pathway, Legionellosis, Leishmaniasis, Lipid and atherosclerosis, Malaria, Measles, Pathways in cancer, Pertussis, Proteoglycans in cancer, RIG-I-like receptor signaling pathway, Rheumatoid arthritis, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Type I diabetes mellitus 💬 | [5] 49 49, 50, 93, 96, 97 💬
|
203 | Vitamin D | [1] Vitamin D Vitamin D | - | - | - | [20] 6 6, 13, 19, 41, 43, 44, 46, 49, 50, 68, 93, 95, 96, 97, 179, 222, 228, 235, 274, 299 💬
|
204 | Volixibat | [1] Volixibat Volixibat | [2] Volixibat potassium
Volixibat potassium
,
Volixibat
💬
| - | - | [2] 93 93, 94 💬
|
205 | Volixibat potassium | [1] Volixibat Volixibat | [2] Volixibat potassium
Volixibat potassium
,
Volixibat
💬
| - | - | [2] 93 93, 94 💬
|
206 | Zoledronic acid | [1] Zoledronic acid Zoledronic acid | [5] Zoledronic acid
Zoledronic acid
,
Zoledronate disodium
,
Zoledronate trisodium
,
Zoledronic acid
,
Zoledronic acid hemipentahydrate
💬
| [1] FDPS FDPS 💬
| [3] Human T-cell leukemia virus 1 infection Human T-cell leukemia virus 1 infection, Influenza A, Terpenoid backbone biosynthesis 💬 | [13] 6 6, 13, 46, 75, 77, 93, 95, 96, 97, 270, 274, 299, 333 💬
|